'Increased evidence that we should be alert': H5N1 bird flu is adapting to mammals in 'new ways'
New research suggests the virus is increasingly adapting to mammalian hosts.
Source: livescience.com
Rxiv June News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rxiv June. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rxiv June Today - Breaking & Trending Today
The Pandemic Cause No One Wants to Talk About
Public health officials made SARS-CoV-2 the primary target for pandemic measures. Are there other toxic stressors you need ...
Source: theepochtimes.com
EUSA Pharma Announces First Patient Enrolled in a Randomised Phase 3 Clinical Trial Investigating Siltuximab in Hospitalised Patients with COVID-19- or Another Respiratory Virus Infection-Associated Acute Respiratory Distress Syndrome (ARDS)
SISCO’) study. 1 The results from 30 patients treated with siltuximab in the ‘SISCO’ study compared with 30 matched controls, showed that treatment with siltuximab led to a 54% reduction in risk of 30-day all-cause mortality. 2 This pivotal study will evaluate the efficacy and safety of standard of care (SOC) with or without intravenous siltuximab in selected hospitalised patients with COVID-19 previously treated with corticosteroids or another respiratory virus infection. Unlike previous studies of agents targeting the interleukin-6 (IL-6) signalling pathway, the ‘SILVAR’ study has...
Source: financialbuzz.com